Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
批准号:
8639259
负责人:
NEIL J. FREEDMAN
金额:
$47.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-03 至 2018-01-31
关键词:
AffectAnti-Inflammatory AgentsAnti-inflammatoryAntiatherogenicAntibodiesAtherosclerosisBindingBlood VesselsBreedingCause of DeathCell ProliferationCustomCytokine ReceptorsDeubiquitinationDietG-Protein-Coupled ReceptorsGene ExpressionGenesGoalsGrowth Factor ReceptorsHealthHumanHyperplasiaIRAK1 geneIn VitroInflammatoryInterleukin-1 ReceptorsIon ChannelIonsLinkMAPK3 geneMediatingMethodsModelingMolecularMusPhosphorylationPhosphotransferasesPhysiologicalPolyubiquitinationPost-Translational Protein ProcessingPreparationProcessProtein DephosphorylationProtein IsoformsProteinsReagentRegulationRoleSignal TransductionSignaling ProteinSmooth Muscle MyocytesStimulusSystemTNF geneTRAF2 geneTRAF6 geneTechniquesTestingTransgenic MiceTumor Necrosis Factor ReceptorUbiquitinationUnited Statesatherogenesisatheroprotectivebasecell motilitycongeniccytokinefeedingin vivointerleukin-1 receptor-associated kinasemigrationnew therapeutic targetnovelpreventpromoterprototyperesponsescaffoldstress-activated protein kinase 1toll-like receptor 4transcription factorubiquitin-protein ligaseubiquitin-specific protease
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Atherosclerosis remains a leading cause of death in the United States. Accumulating evidence suggests that aortic wall smooth muscle cell gene expression contributes substantially to atherogenesis. ß-arrestin2 (ßarr2) an endocytic and signaling adaptor for G protein-coupled receptors (GPCRs), growth factor receptors and ion- channels is also known to promote neointimal hyperplasia and atherosclerosis in mice. Reversible ßarr2 ubiquitination, as regulated by deubiquitinases (DUBs) is a critical post-translational modification that is required for ßarr2's adaptor functions in mediating cell-signaling. Our Preliminary Studies suggests that the DUB USP20 might affect ßarr2 ubiquitination as well as NFκB signaling induced by the atherogenic Toll-like receptor 4 (TLR4). To delineate the role(s) of ßarr2 ubiquitination/deubiquitination dynamics in vivo and to evaluate whether the ubiquitination status of ßarr2 could engender pro-inflammatory signaling in SMCs, we have generated transgenic mice expressing USP20 or its catalytically inactive isoform (DN-USP20) under control of the SMC-specific SM22α promoter. In this model, we expect that by de-ubiquitinating ßarr2, USP20 would reduce ßarr2 activity and thereby reduce the SMC pro-atherogenic proliferation and migration that engenders neointimal hyperplasia, whereas the DN-USP20 would have reciprocal effects. By utilizing these and additional novel reagents and in vivo methods involving diet and gene-dependent atherosclerosis and in vitro techniques employing primary vascular smooth muscle cells we will test the hypotheses that USP20 in SMCs mitigates atherosclerosis through mechanisms involving deubiquitination of ßarr2, and/or deubiquitination of TRAF6 or TRAF2 in a manner dependent upon ßarr2 scaffolding by accomplishing following specific aims: (1) To determine the atheroprotective role of SMC USP20, and whether USP20's mechanism of action requires de-ubiquitination of ßarr2 (2) To determine whether USP20 activity regulates ßarr2-dependent SMC proliferation, migration and signaling triggered by inflammatory stimuli and (3) To elucidate the mechanistic basis of USP20's effects on ßarr2-dependent signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
-
批准号:10670399
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2022
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
-
批准号:10502380
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2022
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Anti-Atherogenic Mechanisms of Drebrin
-
批准号:10318175
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2019
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Anti-Atherogenic Mechanisms of Drebrin
-
批准号:10532356
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2019
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
-
批准号:9765984
-
项目类别:
-
资助金额:$53.35万
-
财政年份:2019
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
-
批准号:9893026
-
项目类别:
-
资助金额:$53.46万
-
财政年份:2019
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Anti-Atherogenic Mechanisms of Drebrin
-
批准号:9887940
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2019
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
-
批准号:10349573
-
项目类别:
-
资助金额:$53.46万
-
财政年份:2019
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
-
批准号:10112295
-
项目类别:
-
资助金额:$53.46万
-
财政年份:2019
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
-
批准号:8797106
-
项目类别:
-
资助金额:$46.83万
-
财政年份:2014
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Anti-atherogenic Mechanisms of the Dual Rho-GEF Kalirin
-
批准号:8760703
-
项目类别:
-
资助金额:$46.72万
-
财政年份:2014
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Anti-atherogenic Mechanisms of the Dual Rho-GEF Kalirin
-
批准号:8894586
-
项目类别:
-
资助金额:$46.6万
-
财政年份:2014
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Aging, Atherosclerosis, and the Arterial Wall
-
批准号:7229958
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2006
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Aging, Atherosclerosis, and the Arterial Wall
-
批准号:7032831
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2006
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Mechanisms of Arterial Wall-Mediated Atherogenesis
-
批准号:6968887
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2005
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Desensitization of Vascular Receptor Tyrosine Kinases
-
批准号:7473891
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Mechanisms of Arterial Wall-Mediated Atherogenesis
-
批准号:7460539
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Desensitization of Vascular Receptor Tyrosine Kinases
-
批准号:7261957
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Desensitization of Vascular Receptor Tyrosine Kinases
-
批准号:7652397
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:NEIL J. FREEDMAN
-
依托单位:
Mechanisms of Arterial Wall-Mediated Atherogenesis
-
批准号:7093608
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2005
-
负责人:NEIL J. FREEDMAN
-
依托单位:
海外基金